ICON PLC — Investor Relations & Filings

ICON PLC is a global provider of outsourced development and commercialization services for the pharmaceutical, biotechnology, and medical device sectors. The company supports clients in accelerating the development of drugs and devices, offering a comprehensive suite of services that span the entire clinical lifecycle from "molecule to medicine." Core capabilities include consulting, early clinical and bioanalytical solutions, site and patient solutions, specialty laboratory services supporting precision medicine, and market access strategies covering pricing and reimbursement. ICON also delivers specialized biotech support, such as due diligence and asset valuation, alongside advanced cardiac safety solutions. The company integrates healthcare intelligence and technology, including artificial intelligence, to enhance clinical research processes.